Cite
HARVARD Citation
Sanborn, R. et al. (2017). A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113. Cancer. 123 (2), pp. 303-311. [Online].